Arecor is steadily building its patent portfolio, which covers the Company’s core enabling technologies for the stabilisation of biologics and applications in the formulation of specific products. These patent families, together with the Company’s proprietary know-how, provide Arecor and its clients with a wide range of technical options, which can be used separately or in combination to create differentiated solutions for individual bioliogics. Overall the patent portfolio covers three different segments of our technology platform: Arestat-T™ (protection against thermally induced degradation), Arestat-C™ (protection against concentration induced degradation) and Arestat-R™ (protection during exposure to ionising radiation) technologies. A list of published applications is shown in the table below.

Arecor works in close coordination with its European and US patent advisors to ensure that Arecor’s core technologies are protected by robust and defensible patent claims. This approach is of benefit to clients of Arecor seeking an enhanced IP position in conjunction with improved formulations of their products.

Our IP strategy also recognises the role of IP in maintaining competitive advantage and thereby improve the sustainability of Arecor’s business, Combined with an awareness of critical market needs, this drives an ongoing investment in our technology platform to create relevant and cost-effective solutions for formulation of biologics.

ARECOR PUBLISHED PATENT APPLICATIONS